Monday, November 20, 2023
Category: Immunocompromised Host, Infectious in Oncology, Mould Infections, Transplant Infectious Diseases
Dr. Aliyah Baluch, Program Lead for Bone Marrow Transplant Infectious Diseases at Moffitt Cancer Center and Research Institute, reviews Important opportunistic fungal pathogens of relevance to the stem cell transplant and immunocompromised patient. Dr. Baluch beings by discussing the pharmacologic options for aspergillus treatment and their individual mechanisms of action. Next, through a case-based format, she reviews specific scenarios related to fungal infections with Aspergillus, Mucor, and Sporothrix. Lastly, new agents in the antifungal pipeline are discussed, and a robust question and answer session closes the presentation.
Stay in touch! Download our app in the iTunes store or the Google Marketplace.
